Loss of vascular adhesion protein-1 expression in intratumoral microvessels of human skin melanoma

Melanoma Research

Volumn 14, Issue 2, 2004, Pages 135-140

  Forster Horváth, Csaba ^a   Döme, Balázs ^b   Paku, Sándor ^b   Ladányi, Andrea ^a   Somlai, Beáta ^b   Jalkanen, Sirpa ^c   Tímár, József ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Intratumoral vessels; Melanoma; Survival; Vascular adhesion protein 1

Indexed keywords

VASCULAR ADHESION PROTEIN 1;

ARTICLE; BLOOD VESSEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; MALE; MELANOMA; MICROVASCULATURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; THICKNESS;

AMINE OXIDASE (COPPER-CONTAINING); BLOOD VESSELS; CELL ADHESION MOLECULES; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MICROCIRCULATION; MICROSCOPY, IMMUNOELECTRON; MYOCYTES, SMOOTH MUSCLE; SKIN NEOPLASMS;

EID: 18844466867     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200404000-00010     Document Type: Article

References (23)

1. Döme B, Paku S, Somlai B, Tímár J. Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance. J Pathol 2002; 197:355-362.
2. McDonald DM, Foss AJE. Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev 2002; 19:109-120.
3. Warren BA. The vascular morphology of tumors. In: Peterson H-I (editor): Tumor blood circulation: angiogenesis, vascular morphology and blood flow of experimental and human tumors. Boca Raton: CRC Press; 1979, pp. 1-48.
4. Konerding MA, Steinberg F, Streffer C. The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. II. Scanning and transmission electron microscopic studies. Acta Anat 1989; 136:27-33.
5. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988; 133:95-109.
6. Less JR, Skalak TC, Sevick EM, Jain RK. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 1991; 51:265-273.
7. Kohn S, Nagy JA, Dvorak HF, Dvorak AM. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 1992; 67:596-607.
8. Konerding MA, Miodonski AJ, Lametschwandtner A. Microvascular corrosion casting in the study of tumor vascularity: a review. Scanning Microsc 1995; 9:1233-1243.
9. Less JR, Posner MC, Skalak TC, Wolmark N, Jain RK. Geometric resistance and microvascular network architecture of human colorectal carcinoma. Microcirculation 1997; 4:25-33.
10. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156:1363-1380.
11. Paku S, Paweletz N. First steps of tumor-related angiogenesis. Lab Invest 1991; 65:334-346.
12. Feng D, Nagy JA, Dvorak AM, Dvorak HF. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res 2000; 59:24-37.
13. Salmi M, Jalkanen S. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol 1997; 64: 139-218.
14. Jaakkola K, Kaunismäki K, Tohka S, Yegutkin G, Vänttinen E, Havia T, et al. Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol 1999; 155:1953-1965.
15. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 1998; 188:17-27.
16. Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992; 257:1407-1409.
17. Arvilommi A-M, Salmi M, Kalimo K, Jalkanen S. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1). Eur J Immunol 1996; 26:825-833.
18. Arvilommi A-M, Salmi M, Jalkanen S. Organ-selective regulation of vascular adhesion protein-1 expression in man. Eur J Immunol 1997; 27:1794-1800.
19. Irjala H, Salmi M, Alanen K, Grénman R, Jalkanen S. Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium. J Immunol 2001; 166:6937-6943.
20. Yoong KF, McNab G, Hübscher SG, Adams DH. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J Immunol 1998; 160:3978-3988.
21. Jaakkola K, Nikula T, Holopainen R, Vähäsilta T, Matikainen M-T, Laukkanen ML, et al. In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol 2000; 157:463-471.
22. Thörn M, Pontén F, Bergström R, Sparén P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994; 86: 761-769.
23. Barnhill RL, Fine JA, Roush GC, Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 1996; 78:427-432.